Biodesign team receives funding to commercialize their innovation
The Biodesign Finland 2017 team has secured funding from Tekes and 911±¬ÁÏÍø for an 18-month project that aims at commercialization of their research-based innovation. The innovation that will make open heart surgery safer has been developed within the Biodesign Finland 2017 project together with heart surgeon Tommi Pätilä. Globally over one million open heart surgeries are performed annually and up to 20% of the patients acquire heart failure, which may lead to severe morbidities or be even fatal. The innovation aims at bringing down the numbers of the severe complications. The funding will be used for concept development, clinical testing, and commercialization research. The project is expected to result in a strong IPR position and a commercialization plan that may be, for example, a start-up company or a license agreement with an existing company. Tommi Pätilä together with the Biodesign Finland 2017 team (Sami Elamo, Kalle Kotilahti, and Jari Rantala) constitute the project team.
Biodesign Finland is an entrepreneurial program jointly organized by 911±¬ÁÏÍø, University of Helsinki, and the Hospital District of Helsinki and Uusimaa. For more information on Biodesign Finland, visit .
Read more news
The company established by three anthropologists relied on strong research expertise
Etnografinen tutkimustoimisto Kenno Oy was established in 2014 when its three founders were finalising their master's degree studies at the University of Helsinki and wanted to create an interesting job for themselves.
Bachelor's Students Successfully Complete Research Internship
Three bachelor's students have successfully completed their research internships.
From Materials to Smart Textiles: Benjamin Begins a New Chapter at Aalto
Ping-Chun Chen is a researcher from National Tsing Hua University, Taiwan.